Mostrar el registro sencillo del ítem

dc.contributor.author
Alonso, Maria del Rosario  
dc.contributor.author
Anesini, Claudia Alejandra  
dc.contributor.author
Martino, Renzo Fabricio  
dc.contributor.other
Sülsen, Valeria Patricia  
dc.contributor.other
Martino, Virginia Susana  
dc.date.available
2022-10-24T10:08:25Z  
dc.date.issued
2018  
dc.identifier.citation
Alonso, Maria del Rosario; Anesini, Claudia Alejandra; Martino, Renzo Fabricio; Anti-inflammatory Activity; Springer; 2018; 1-500  
dc.identifier.isbn
978-3-319-78273-7  
dc.identifier.uri
http://hdl.handle.net/11336/174457  
dc.description.abstract
Abstract It is known that inflammation involves a complex series of protective andreparative responses to tissue injury caused by either mechanical and autoimmunestimuli or infection. Inflammation can be either acute or chronic. In the acute phase,in the early stages of inflammation, neutrophils, macrophages, and dendritic cellscontribute to cytokine production that spreads the inflammatory events. Althoughinflammation has a protective role, many diseases have the etiological origin ininflammatory processes such as atherosclerosis, arthritis, cancer, and ischemic heartdisease. There are many pathways involving the synthesis and secretion of pro-inflammatorymediators. In this chapter we analyze different intracellular signalingroutes related to inflammation. There are two principal types of anti-inflammatorydrugs, namely, steroidal anti-inflammatory drugs, which reduce inflammation bybinding to cortisol receptors and nonsteroidal anti-inflammatory drugs, whichdecrease damage by inhibition of cyclooxygenase enzymes. These anti-inflammatorydrugs entail many risks, in particular, gastrointestinal ulceration, bleeding, and hepatotoxicity.Over the last decades, the potential of sesquiterpene lactones as anti-inflammatoryagents has been pointed out by different authors.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
Springer  
dc.rights
info:eu-repo/semantics/restrictedAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/  
dc.subject
SESQUITERPENE LACTONES  
dc.subject
ANTI_INFLAMMATORY  
dc.subject.classification
Otras Ciencias de la Salud  
dc.subject.classification
Ciencias de la Salud  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.title
Anti-inflammatory Activity  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.type
info:eu-repo/semantics/bookPart  
dc.type
info:ar-repo/semantics/parte de libro  
dc.date.updated
2022-06-21T19:24:32Z  
dc.journal.pagination
1-500  
dc.journal.pais
Suiza  
dc.journal.ciudad
Cham  
dc.description.fil
Fil: Alonso, Maria del Rosario. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Química y Metabolismo del Fármaco. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Instituto de Química y Metabolismo del Fármaco; Argentina  
dc.description.fil
Fil: Anesini, Claudia Alejandra. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Química y Metabolismo del Fármaco. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Instituto de Química y Metabolismo del Fármaco; Argentina  
dc.description.fil
Fil: Martino, Renzo Fabricio. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Química y Metabolismo del Fármaco. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Instituto de Química y Metabolismo del Fármaco; Argentina  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://link.springer.com/chapter/10.1007/978-3-319-78274-4_14#:~:text=There%20are%20two%20principal%20types,by%20inhibition%20of%20cyclooxygenase%20enzymes.  
dc.conicet.paginas
500  
dc.source.titulo
Sesquiterpene lactones: Advances in their Chemistry and Biological Aspects